Endocrinology meetings & conferences

7th International Conference on Advanced Technologies & Treatments for Diabetes

February 5-8 2014 Vienna, Austria

Filling a unique niche, the 7th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD 2014) will attract an international audience of researchers and clinicians as well as developers from the medical technology industry.

Since the inaugural ATTD meeting in 2008, ATTD gatherings have grown dramatically. ATTD 2014 will build on the success of previous annual meetings and present the latest technological advances in treatment of diabetes and related conditions.

Join us for ATTD 2014 in majestic Vienna, Austria, February 5-8 2014 for unparalleled access to unique scientific knowledge as well as valuable networking opportunities.

Contact Us

c/o Kenes International
1-3 Rue de Chantepoulet
P.O. Box 1726
CH-1211 Geneva 1, Switzerland
Tel: +41 22 908 04 88, Fax: + 41 22 906 9140
E-mail: attd@kenes.com
Website: www.kenes.com/attd

3rd Global Congress for Consensus in Pediatrics & Child Health

February 13-16, 2014 Bangkok, Thailand

The concept for the CIP congress and program was developed for Pediatricians working in Primary and Secondary Care, as well as for specialists in the diverse areas of Pediatrics, Pediatric Surgeons, Family Medicine Doctors, General Practitioners, Researchers and Policy Makers

Main Topics

Primary Care

Neonatology

Pediatric Allergy & Immunology

Critical & Intensive Care

Pediatric Dermatology

Emergency Medicine

Pediatric Education

Pediatric Endocrinology

Pediatric Gastroenterology

Social Pediatrics

Pediatric Genetics

Hematology & Oncology

Infectious Diseases and Vaccinology

Pediatric Nephrology

Pediatric Neurology

Developmental-Behavioral Pediatrics

Pulmonology and Sleep Medicine

Pediatric Psychiatry

Pediatric Radiology

Pediatric Rheumatology

Pediatric Nutrition

Pediatric Sports Medicine

Adolescent Health

Surgery and its specialties

Rare and Orphan diseases

Pharmacology and Toxicology

Contact Us

Paragon Conventions
Tel: +41 (0)22 533 0948 Fax: +41 (0)22 580 2953
Email: cip@cipediatrics.org

5th International Conference on Fixed Combination in the Treatment of Hypertension, Dyslipidemia and Diabetes Mellitus

21-24 November, 2013 Bangkok, Thailand

Fixed combination has recently made a comeback as an initial therapy in the treatment of hypertension. The additive or synergistic effect of combination therapy fully lowers blood pressure in patients who tend to have less than full response to one component only. Antihypertensive monotherapy does not address the multifactorial nature of hypertension as a disease with many pathways; using more than one drug makes more therapeutic sense, as combined agents cover more than one etiology.

Importance of anti-diabetic and anti-lipidemic combinations should be emphasized as well: Many patients with diabetes mellitus may also be treated with dual pharmacological therapy as fixed combination: two or more drugs acting on different pathophysiological process is often  necessary to reach  early and sustained achievement of individualized  glycemic targets. At the same time choosing the safest option to avoid hypoglycemia is of paramount importance compared with loose pill, both statin and anti-diabetic combination therapies may also have better adherence, improved satisfaction and lower drug costs.

The conference is intended for experts in the fields of diabetes, hypertension, dyslipidemia, internal medicine, cardiology, endocrinology, nephrology, hyperlipidemia, family medicine, primary care physicians, nurse practitioners and physicians’ assistants. All are invited to explore the current and future role of fixed combinations in the treatment of hypertension, dyslipidemia and diabetes.

List of Topics

•  Treatment Simplification and Compliance

•  FDCs as First Step Treatment

•  FDC in Secondary Prevention

•  FDCs of Antihypertensive and Antidiabetic Drugs

•  FDCs of Antihypertensive and Lipid Lowering Drugs

•  FDC in the Elderly and Very Elderly

•  Ambulatory BP in the Assessment of FDC Efficacy

•  Home BP in the Assessment of FDC Efficacy

•  Combinations with Thiazides. Chlortalidone vs HCTZ

•  ACE Inhibitors  and  Diuretics FDC

•  ACE Inhibitors  and  Calcium Channel Blockers FDC

•  ARBs  and Diuretics  FDC

•  ARBs  and Calcium Channel Blockers  FDC

•  Triple Drug Combinations

•  The Polypills

•  FDCs as Generic Drugs

•  Guidelines

•  FDCs in Different Countries

•  Regulatory Aspects

•  Cost Issues

Contact Us

Conference Organizers

Paragon Conventions
18 Avenue Louis-Casai
1209 Geneva, Switzerland
Tel:  +41 (0)22 533 0948    
Fax: +41 (0)22 580 2953

General Enquiries

Noa Beer-Raveh - Project Manager
fixed2013@fixedcombination.com  
Fax: +41 (0)22 580 2953

4th Arab Diabetes Forum

4-6 September 2013 Cairo, Egypt

Target Audience

Physicians, researchers, nurses, nurse practitioners, dietitians, podiatrists, pharmacists, psychologists, Endocrinologists, Diabetes Educators, People interested in diabetes, People with diabetes, Diabetes health professionals, and other health care professionals.

Theme Areas

1- KOL Meetings for Arab Diabetes Alliance.

2- Diabetes in the Arab World:

•Prevalence / Registry
•Cost / Complications
•Cultural Aspects
•Arabic Guidelines

3- Debates and controversies:

•Safety and Efficacy
•Hypos versus hyperglycemia
•Guidelines: which?

4- Workshops and Education Programs.

5- Updates in

•Understanding pathogenesis
•New therapies
•Diabetic dyslipidemia

83rd Annual Meeting of the American Thyroid Association

October 16-20, 2013 San Juan, Puerto Rico

At the 83rd Annual Meeting of the American Thyroid Association (ATA), attendees will experience top-notch educational sessions, great networking opportunities and unmatched collegiality. 

The American Thyroid Association is the leading organization focused on thyroid biology and the prevention and treatment of thyroid disorders through excellence and innovation in research, clinical care, education, and public health. Earn CME credits, hear innovative talks on clinical topics, participate in interactive sessions, develop professionally with state of the art information, and meet with friends and colleagues.

The ATA meeting is designed for the community of endocrinologists, internists, surgeons, basic scientists, nuclear medicine scientists, pathologists, endocrine, fellows, nurses, physician assistants and other health care professionals who wish to broaden and update their knowledge of the thyroid gland and its disorders. Clinical, basic and surgical fellows will have customized educational tracks to enhance their meeting experience.

World Diabetes Congress

The next World Diabetes Congress will be held at the Melbourne Convention and Exhibition Centre, Melbourne, Australia from 2 to 6 December 2013.

The International Diabetes Federation is the global voice for people with diabetes and those at risk. Twenty years after the World Diabetes Congress in Japan, the Western Pacific Region is again in the global health spotlight and is why we have chosen Melbourne to host the World Diabetes Congress in 2013.

Today, more than a third of all people with diabetes are found in the Western Pacific Region. It is also the region that has the highest number of undiagnosed cases and the highest number of deaths attributable to diabetes.

European Academy of Paediatrics 2013 Congress and MasterCourse

19-22 September, 2013 Lyon, France

The 2013 EAP Congress and MasterCourse, EAP will continue our  mission to train, educate, and update those professionals taking care of children, while at the same time stimulating and allowing the delegates the opportunity to meet and/or create personal professional network of colleagues and friends. The 2013 EAP Congress is the perfect setting to get the most updated, state-of-the-art information on the latest developments in research and clinical practice in the main areas of Paediatrics. It also provide the opportunity to debate on controversial issues and to contribute to the progress of the practice of paediatrics.

Congress Topics

    
Adolescent Medicine
Allergy and Immunology
Critical / Emergency Care
Endocrine & Diabetes
Gastroenterology and Nutrition
Genetic & Metabolic
Hemato - Oncology
Infectious Diseases

Neonatology
Nephrology
Neurology
Obesity
Paediatric Tropical Medicine
Primary Care
Respiratory
Rheumatology

MasterCourse Topics

Gastroenterology
Nutrition

Paragon-Conventions
18 Avenue Louis-Casai
1209 Geneva
Switzerland

Tel: +41 22 5330 948
Fax: +41 22 5802 953
Email: congress@eapaediatrics.eu
http://www.paragon-conventions.com

3rd World Congress of the International Society for Fertility Preservation (ISFP)

November 7-9, 2013 Valencia, Spain

We invite you to take part in the 3rd World Congress on the International Society for Fertility Preservation (ISFP) which will take place in Valencia, Spain on November 7-9, 2013.

Fertility preservation is a substantial quality of life issue for young cancer survivors. As a consequence, the demand for fertility preservation has dramatically increased. The aim of the Congress is to update current scientific and clinical development of fertility preservation strategies. The Congress will not only propagate the current knowledge but also provide an opportunity for networking.

This congress is designed for reproductive endocrinologists, hematology-oncologists, gynecologic oncologists, psychologists, basic scientists, clinical researchers, oncology nurses, REI nurses, oncology social workers and others interested in fertility preservation.

During this congress, participants will be able to:

- Educate medical professionals to facilitate FP referrals
- Define the ethical and legal issues related to FP
- Explain the impact of cancer treatment on fertility and reproduction.
- Evaluate the current status of gamete Cryopreservation.
- Assess the strategies and values of emerging technology in ovarian transplantation.
- Recognize basic physiology and effects of Cryopreservation.
- Analyze physiology and current techniques of folliculogenesis and IVM.
- Identify new fertility preservation technologies